Alcon Inc. (SWX:ALC)
81.24
+0.68 (0.84%)
Feb 21, 2025, 5:35 PM CET
Alcon Revenue
Alcon had revenue of $2.45B USD in the quarter ending September 30, 2024, with 5.37% growth. This brings the company's revenue in the last twelve months to $9.76B, up 5.25% year-over-year. In the year 2023, Alcon had annual revenue of $9.46B with 8.47% growth.
Revenue (ttm)
$9.76B
Revenue Growth
+5.25%
P/S Ratio
4.87
Revenue / Employee
$385.58K
Employees
25,315
Market Cap
40.18B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
Dec 31, 2019 | 7.51B | 355.00M | 4.96% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Lonza Group AG | 6.57B |
Galderma Group AG | 3.88B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.09B |
Sonova Holding AG | 3.71B |
Ypsomed Holding AG | 617.07M |
Alcon News
- 3 days ago - Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension - Business Wire
- 18 days ago - Alcon: An Eyecare Leader With Strong Profit Margins, But Overheated Valuation - Seeking Alpha
- 7 weeks ago - FDA Announces Popular Eye Drop Recall Over Fungal Contamination - Yahoo
- 7 weeks ago - Alcon Inc (ALC) to Present at 2025 J.P. Morgan Healthcare Conference - GuruFocus
- 7 weeks ago - Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference - Business Wire
- 7 weeks ago - Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Systane eye drops recalled due to fungal contamination: FDA - Yahoo
- 2 months ago - Alcon a top pick for 2025 at Needham on upcoming product launches - Seeking Alpha